From the Department of Radiation Oncology, Haydarpaşa Numune Training and Research Hospital, University of Health Sciences.
Department of Nuclear Medicine, Yeditepe University School of Medicine.
Clin Nucl Med. 2020 Apr;45(4):330-333. doi: 10.1097/RLU.0000000000002964.
We present the case of a 67-year-old man with prostate cancer who had no findings of recurrence, except diffuse radiotracer uptake in the bone marrow in Ga-PSMA PET/CT. Bone marrow uptake was also represented as multiple focal increased spots without any corresponding lytic or sclerotic lesions in CT. MRI revealed a high and homogeneous T2 signal within the bone marrow, without any contrast-enhanced or diffusion-restricted lesions. Further workup, including a bone marrow biopsy, revealed the diagnosis of myelodysplastic syndrome.
我们报告了一例 67 岁前列腺癌患者，除了 Ga-PSMA PET/CT 显示骨髓弥漫性放射性示踪剂摄取外，没有发现任何复发迹象。骨髓摄取也表现为多个局灶性点状高信号，CT 无相应溶骨性或硬化性病变。MRI 显示骨髓内高信号且均匀，无增强或弥散受限病变。进一步检查，包括骨髓活检，提示骨髓增生异常综合征的诊断。
